{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:20:22Z","timestamp":1769581222236,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T00:00:00Z","timestamp":1328572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1007\/s12020-012-9618-y","type":"journal-article","created":{"date-parts":[[2012,2,6]],"date-time":"2012-02-06T14:57:16Z","timestamp":1328540236000},"page":"410-414","source":"Crossref","is-referenced-by-count":28,"title":["Mini-review: new therapeutic options in hypoparathyroidism"],"prefix":"10.1007","volume":"41","author":[{"given":"Natalie E.","family":"Cusano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mishaela R.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"James","family":"Sliney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,7]]},"reference":[{"key":"9618_CR1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1590\/S0004-27302010000200019","volume":"54","author":"MR Rubin","year":"2010","unstructured":"M.R. Rubin, J.P. Bilezikian, Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement. Arq. Bras. Endocrinol. Metab. 54, 220\u2013226 (2010)","journal-title":"Arq. Bras. Endocrinol. Metab."},{"key":"9618_CR2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","volume":"335","author":"SH Pearce","year":"1996","unstructured":"S.H. Pearce, C. Williamson, O. Kifor et al., A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N. Engl. J. Med. 335, 1115\u20131122 (1996)","journal-title":"N. Engl. J. Med."},{"key":"9618_CR3","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1210\/jc.84.10.3792","volume":"84","author":"T Sunthornthepvarakul","year":"1999","unstructured":"T. Sunthornthepvarakul, S. Churesigaew, S. Ngowngarmratana, A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism. J. Clin. Endocrinol. Metab. 84, 3792\u20133796 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9618_CR4","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1359\/jbmr.080803","volume":"23","author":"MR Rubin","year":"2008","unstructured":"M.R. Rubin, D.W. Dempster, H. Zhou et al., Dynamic and structural properties of the skeleton in hypoparathyroidism. J. Bone Miner. Res. 23, 2018\u20132024 (2008)","journal-title":"J. Bone Miner. Res."},{"key":"9618_CR5","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1210\/jc.76.6.1617","volume":"76","author":"S Abugassa","year":"1993","unstructured":"S. Abugassa, J. Nordenstrom, S. Eriksson, G. Sjoden, Bone mineral density in patients with chronic hypoparathyroidism. J. Clin. Endocrinol. Metab. 76, 1617\u20131621 (1993)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9618_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/00000441-199508000-00003","volume":"310","author":"JS Touliatos","year":"1995","unstructured":"J.S. Touliatos, J.I. Sebes, A. Hinton et al., Hypoparathyroidism counteracts risk factors for osteoporosis. Am. J. Med. Sci. 310, 56\u201360 (1995)","journal-title":"Am. J. Med. Sci."},{"key":"9618_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","volume":"46","author":"MR Rubin","year":"2010","unstructured":"M.R. Rubin, D.W. Dempster, T. Kohler et al., Three dimensional cancellous bone structure in hypoparathyroidism. Bone 46, 190\u2013195 (2010)","journal-title":"Bone"},{"key":"9618_CR8","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/jbmr.452","volume":"26","author":"MR Rubin","year":"2011","unstructured":"M.R. Rubin, D.W. Dempster, J. Sliney Jr. et al., PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J. Bone Miner. Res. 26, 2727\u20132736 (2011)","journal-title":"J. Bone Miner. Res."},{"key":"9618_CR9","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1002\/jbmr.470","volume":"26","author":"T Sikjaer","year":"2011","unstructured":"T. Sikjaer, L. Rejnmark, L. Rolighed et al., The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J. Bone Miner. Res. 26, 2358\u20132370 (2011)","journal-title":"J. Bone Miner. Res."},{"key":"9618_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1056\/NEJMcp0803050","volume":"359","author":"D Shoback","year":"2008","unstructured":"D. Shoback, Clinical practice. Hypoparathyroidism. N. Engl. J. Med. 359, 391\u2013403 (2008)","journal-title":"N. Engl. J. Med."},{"key":"9618_CR11","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"J.P. Bilezikian, A. Khan, J.T. Potts Jr. et al., Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J. Bone Miner. Res. 26, 2317\u20132337 (2011)","journal-title":"J. Bone Miner. Res."},{"key":"9618_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1530\/eje.0.1460215","volume":"146","author":"W Arlt","year":"2002","unstructured":"W. Arlt, C. Fremerey, F. Callies et al., Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur. J. Endocrinol. 146, 215\u2013222 (2002)","journal-title":"Eur. J. Endocrinol."},{"key":"9618_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12020-011-9570-2","volume":"41","author":"G Mazziotti","year":"2012","unstructured":"G. Mazziotti, J. Bilezikian, E. Canalis et al., New understanding and treatments for osteoporosis. Endocrine 41, 58\u201369 (2012)","journal-title":"Endocrine"},{"key":"9618_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","volume":"276","author":"KK Winer","year":"1996","unstructured":"K.K. Winer, J.A. Yanovski, G.B. Cutler Jr., Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA 276, 631\u2013636 (1996)","journal-title":"JAMA"},{"key":"9618_CR15","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1210\/jc.83.10.3480","volume":"83","author":"KK Winer","year":"1998","unstructured":"K.K. Winer, J.A. Yanovski, B. Sarani, G.B. Cutler Jr., A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J. Clin. Endocrinol. Metab. 83, 3480\u20133486 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9618_CR16","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1210\/jc.2002-021736","volume":"88","author":"KK Winer","year":"2003","unstructured":"K.K. Winer, C.W. Ko, J.C. Reynolds et al., Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J. Clin. Endocrinol. Metab. 88, 4214\u20134220 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9618_CR17","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1210\/jc.2009-2464","volume":"95","author":"KK Winer","year":"2010","unstructured":"K.K. Winer, N. Sinaii, J. Reynolds et al., Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. J. Clin. Endocrinol. Metab. 95, 2680\u20132688 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9618_CR18","doi-asserted-by":"crossref","unstructured":"K.K. Winer, B. Zhang, J.A. Shrader et al., Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J. Clin. Endocrinol. Metab. (2011) [Epub ahead of print]","DOI":"10.1210\/jc.2011-1908"},{"key":"9618_CR19","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","volume":"21","author":"MR Rubin","year":"2010","unstructured":"M.R. Rubin, J. Sliney Jr., D.J. McMahon et al., Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos. Int. 21, 1927\u20131934 (2010)","journal-title":"Osteoporos. Int."},{"key":"9618_CR20","unstructured":"N.E. Cusano, M.R. Rubin, D. McMahon D et al., Treatment of Hypoparathyroidism with PTH(1-84) is safe and effective for up to 4 years. J. Bone Miner. Res. 26(Suppl 1), S34 (2011). \n                    http:\/\/www.asbmr.org\/Meetings\/AnnualMeeting\/Abstract2011.aspx\n                    \n                  . Accessed 11\/04\/11"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-012-9618-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9618-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9618-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T19:40:42Z","timestamp":1581968442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-012-9618-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,7]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9618"],"URL":"https:\/\/doi.org\/10.1007\/s12020-012-9618-y","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,7]]}}}